
AbstractNeurodegenerative diseases and spinal cord injury affect approximately 50 million people worldwide, bringing the total healthcare cost to over 600 billion dollars per year. Nervous system growth factors, that is, neurotrophins, are a potential solution to these disorders, since they could promote nerve regeneration. An average of 500 publications per year attests to the significance of neurotrophins in biomedical sciences and underlines their potential for therapeutic applications. Nonetheless, the poor pharmacokinetic profile of neurotrophins severely restricts their clinical use. On the other hand, small molecules that modulate neurotrophic activity offer a promising therapeutic approach against neurological disorders. Nature has provided an impressive array of natural products that have potent neurotrophic activities. This Review highlights the current synthetic strategies toward these compounds and summarizes their ability to induce neuronal growth and rehabilitation. It is anticipated that neurotrophic natural products could be used not only as starting points in drug design but also as tools to study the next frontier in biomedical sciences: the brain activity map project.
Physical Injury - Accidents and Adverse Effects, Molecular Conformation, Neurodegenerative, Regenerative Medicine, drug discovery, Small Molecule Libraries, neurodegenerative disease, Humans, Nerve Growth Factors, Spinal Cord Injury, total synthesis, Traumatic Head and Spine Injury, Neurons, Organic Chemistry, Neurosciences, Alzheimer's disease, Chemical sciences, 5.1 Pharmaceuticals, Chemical Sciences, Neurological, Development of treatments and therapeutic interventions, Nervous System Diseases, Alzheimer’s disease, dementia
Physical Injury - Accidents and Adverse Effects, Molecular Conformation, Neurodegenerative, Regenerative Medicine, drug discovery, Small Molecule Libraries, neurodegenerative disease, Humans, Nerve Growth Factors, Spinal Cord Injury, total synthesis, Traumatic Head and Spine Injury, Neurons, Organic Chemistry, Neurosciences, Alzheimer's disease, Chemical sciences, 5.1 Pharmaceuticals, Chemical Sciences, Neurological, Development of treatments and therapeutic interventions, Nervous System Diseases, Alzheimer’s disease, dementia
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 102 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
